Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.6B | 1.7B | 1.6B |
Cost of revenue | 1.2B | 1.2B | 1.3B | 1.3B |
Gross profit | 305M | 349M | 364M | 280M |
Operating expense | ||||
Research & development | 22M | 27M | 27M | 28M |
Selling general and admin | 275M | 289M | 293M | 291M |
Other operating expenses | -36M | 34M | 33M | 39M |
Operating income | 55M | 24M | 28M | -57M |
Non operating interest income | ||||
Income | 2M | 1M | 1M | 2M |
Expense | 40M | 13M | 12M | 11M |
Other income expense | — | — | — | — |
Pretax income | -68M | 2M | -12M | -119M |
Tax provision | -4M | 0 | 4M | -21M |
Net income | -64M | 2M | -16M | -98M |
Basic EPS | — | 0.0 | -0.2 | -1.1 |
Diluted EPS | — | 0.0 | -0.2 | -1.1 |
Basic average shares | — | 76.0M | 76.0M | 76.0M |
Diluted average shares | — | 76.0M | 76.0M | 76.0M |
EBITDA | 118M | 154M | 141M | 32M |
Net income from continuing op. | -68M | 2M | -12M | -119M |
Minority interests | 0 | -1M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |